INCOME STATEMENT
Aarti Drugs Ltd.
BSE
Apr 30
348.75
-2.60 ( -0.74%)
Volume
38637
Prev. Close
351.35
Open Price
347.70
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
349.00
-1.80 ( -0.51%)
Volume
244406
Prev. Close
350.80
Open Price
357.60
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE767A01016
|
Market Cap. ( ₹ in Cr. )
|
3185.32
|
P/BV
|
2.49
|
Book Value ( ₹ )
|
139.96
|
BSE Code
|
524348
|
52 Week High/Low ( ₹ )
|
635/312
|
FV/ML
|
10/1
|
P/E(X)
|
18.58
|
NSE Code
|
AARTIDRUGSEQ
|
Book Closure
|
04/02/2025
|
EPS ( ₹ )
|
18.78
|
Div Yield (%)
|
0.29
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 2253.74 | 2488.71 | 2251.17 | 1914.89 | 1634.92 |
Other Operating Revenues | 13.17 | 9.26 | 0.00 | 0.00 | 0.00 |
Total Operating Revenues | 2266.91 | 2497.97 | 2251.17 | 1914.89 | 1634.92 |
| | | | | |
Other Income | 4.18 | 2.23 | 4.77 | 6.42 | 1.06 |
Total Revenue | 2271.09 | 2500.20 | 2255.95 | 1921.31 | 1635.98 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 1466.57 | 1702.44 | 1524.56 | 1127.79 | 1078.80 |
Purchase Of Stock-In Trade | 35.86 | 47.01 | 58.31 | 43.17 | 40.53 |
Operating And Direct Expenses | 326.86 | 319.57 | 282.81 | 222.37 | 213.66 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 26.77 | -6.72 | -77.94 | -9.08 | -53.94 |
Employee Benefit Expenses | 80.98 | 74.99 | 69.32 | 69.29 | 60.10 |
Finance Costs | 30.16 | 32.53 | 20.07 | 22.61 | 32.20 |
Depreciation And Amortisation Expenses | 47.67 | 47.29 | 47.39 | 47.60 | 46.67 |
Other Expenses | 63.74 | 78.27 | 75.94 | 60.09 | 51.36 |
Total Expenses | 2078.61 | 2295.39 | 2000.45 | 1583.83 | 1469.39 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 192.48 | 204.81 | 255.50 | 337.49 | 166.60 |
| | | | | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.22 | 8.38 |
Profit/Loss Before Tax | 192.48 | 204.81 | 255.50 | 337.71 | 174.97 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 49.60 | 53.25 | 65.50 | 84.50 | 42.25 |
Deferred Tax | 1.00 | -1.25 | -5.00 | -4.50 | -10.25 |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 7.30 |
Total Tax Expenses | 50.60 | 52.00 | 60.50 | 80.00 | 39.30 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 141.88 | 152.81 | 195.00 | 257.71 | 135.67 |
| | | | | |
Profit/Loss From Continuing Operations | 141.88 | 152.81 | 195.00 | 257.71 | 135.67 |
| | | | | |
Profit/Loss For The Period | 141.88 | 152.81 | 195.00 | 257.71 | 135.67 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 15.35 | 16.50 | 21.04 | 27.65 | 58.12 |
Diluted EPS (Rs.) | 15.35 | 16.50 | 21.04 | 27.65 | 58.12 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 9.19 | 9.26 | 9.26 | 23.30 | 6.99 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 1.44 |
Equity Dividend Rate (%) | 10.00 | 10.00 | 10.00 | 25.00 | 20.00 |